<VariationArchive VariationID="1456400" VariationName="NC_000019.9:g.(?_44015579)_(44031339_?)del" VariationType="Deletion" Accession="VCV001456400" Version="4" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-06-10" DateCreated="2022-03-28" MostRecentSubmission="2024-06-09">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1458339" VariationID="1456400">
      <GeneList>
        <Gene Symbol="ETHE1" FullName="ETHE1 persulfide dioxygenase" GeneID="23474" HGNC_ID="HGNC:23287" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>19q13.31</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="43506719" stop="43527201" display_start="43506719" display_stop="43527201" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="44010870" stop="44031395" display_start="44010870" display_stop="44031395" Strand="-" />
          </Location>
          <OMIM>608451</OMIM>
        </Gene>
      </GeneList>
      <Name>NC_000019.9:g.(?_44015579)_(44031339_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>19q13.31</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" forDisplay="true" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" innerStart="44015579" innerStop="44031339" display_start="44015579" display_stop="44031339" variantLength="15761" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000019.9" sequenceAccession="NC_000019" sequenceVersion="9" change="g.(?_44015579)_(44031339_?)del" Assembly="GRCh37">
            <Expression>NC_000019.9:g.(?_44015579)_(44031339_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000019.9:g.(?_44015579)_(44031339_?)del AND Ethylmalonic encephalopathy" Accession="RCV001972374" Version="4">
        <ClassifiedConditionList TraitSetID="587">
          <ClassifiedCondition DB="MedGen" ID="C1865349">Ethylmalonic encephalopathy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-05-19" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2021-05-19" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-03-28" MostRecentSubmission="2024-06-09">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">14732903</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">19136963</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="587" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5013" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Ethylmalonic encephalopathy</ElementValue>
                <XRef ID="Ethylmalonic+Encephalopathy/2662" DB="Genetic Alliance" />
                <XRef ID="MONDO:0011229" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Syndrome of encephalopathy, petechiae, and ethylmalonic aciduria</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">EPEMA syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Encephalopathy, petechiae, and ethylmalonic aciduria</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">EE</ElementValue>
                <XRef Type="MIM" ID="602473" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">EME</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000592488" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000519174" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000551668" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000512633" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000332449" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="2198" />
                <XRef ID="2198" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Ethylmalonic encephalopathy (EE) is a severe, early-onset, progressive disorder characterized by developmental delay / mild-to-severe intellectual disability; generalized infantile hypotonia that evolves into hypertonia, spasticity, and (in some instances) dystonia; generalized tonic-clonic seizures; and generalized microvascular damage (diffuse and spontaneous relapsing petechial purpura, hemorrhagic suffusions of mucosal surfaces, and chronic hemorrhagic diarrhea). Infants sometimes have frequent vomiting and loss of social interaction. Speech is delayed and in some instances absent. Swallowing difficulties and failure to thrive are common. Children may be unable to walk without support and may be wheelchair bound. Neurologic deterioration accelerates following intercurrent infectious illness, and the majority of children die in the first decade.</Attribute>
                <XRef ID="NBK453432" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">28933811</ID>
                <ID Source="BookShelf">NBK453432</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2022">
                <URL>https://www.acmg.net/PDFLibrary/Glutaric-Aciduria-Type-2-ACT-Sheet.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Elevated C4 and C5 +/- Other Acylcarnitines, Glutaric Acidemia II (GA-II) (MADD), 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm,">
                <URL>https://www.acmg.net/PDFLibrary/C4-C5-Elevated-Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, Glutaric Acidemia II (GA-II)/ MADD, Riboflavin Metabolism Disorder, Ethylmalonic Encephalopathy: C4 and C5 elevated +/- other elevated acylcarnitines (AC), 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2022">
                <URL>https://www.acmg.net/PDFLibrary/C4.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Elevated C4 Acylcarnitine, Short-Chain Acyl-CoA Dehydrogenase (SCAD) Deficiency, 2022</CitationText>
              </Citation>
              <XRef ID="51188" DB="Orphanet" />
              <XRef ID="C1865349" DB="MedGen" />
              <XRef ID="MONDO:0011229" DB="MONDO" />
              <XRef Type="MIM" ID="602473" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="4260986" SubmissionDate="2024-06-04" DateLastUpdated="2024-06-09" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="NM_014297.3_19_Deletion (exons 1-4)|MedGen:C1865349" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002241250" DateUpdated="2024-06-09" DateCreated="2022-03-28" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-05-19">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">14732903</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">19136963</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals with ETHE1-related conditions. This variant is a gross deletion of the genomic region encompassing exon(s) 1-4 of the ETHE1 gene, which includes the initiator codon. The 5' end of this event is unknown as it extends beyond the assayed region for this gene and therefore may encompass additional genes. The 3' boundary is likely confined to intron 4 of the ETHE1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ETHE1 are known to be pathogenic (PMID: 14732903, 19136963).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ETHE1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000019.9:g.(?_44015579)_(44031339_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1865349" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11173117</SubmissionName>
          <SubmissionName>SUB12699154</SubmissionName>
          <SubmissionName>SUB14505679</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="4260986" TraitType="Disease" MappingType="XRef" MappingValue="C1865349" MappingRef="MedGen">
        <MedGen CUI="C1865349" Name="Ethylmalonic encephalopathy" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

